Compare with VIPUL DYE CHEM - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENERIC PHARMASEC vs VIPUL DYE CHEM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENERIC PHARMASEC VIPUL DYE CHEM GENERIC PHARMASEC/
VIPUL DYE CHEM
 
P/E (TTM) x 86.8 21.8 398.5% View Chart
P/BV x 8.7 4.0 217.4% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 GENERIC PHARMASEC   VIPUL DYE CHEM
EQUITY SHARE DATA
    GENERIC PHARMASEC
Mar-21
VIPUL DYE CHEM
Mar-21
GENERIC PHARMASEC/
VIPUL DYE CHEM
5-Yr Chart
Click to enlarge
High Rs17188 8.8%   
Low Rs782 8.9%   
Sales per share (Unadj.) Rs0.8124.3 0.6%  
Earnings per share (Unadj.) Rs07.2 0.6%  
Cash flow per share (Unadj.) Rs013.3 0.3%  
Dividends per share (Unadj.) Rs00.90 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs0.740.3 1.9%  
Shares outstanding (eoy) m276.869.55 2,899.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x15.61.1 1,432.0%   
Avg P/E ratio x263.518.8 1,400.8%  
P/CF ratio (eoy) x260.910.2 2,566.4%  
Price / Book Value ratio x16.03.3 479.0%  
Dividend payout %012.5 0.0%   
Avg Mkt Cap Rs m3,3141,289 257.1%   
No. of employees `000NANA-   
Total wages/salary Rs m256 3.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2131,187 18.0%  
Other income Rs m37 50.2%   
Total revenues Rs m2161,194 18.1%   
Gross profit Rs m12161 7.4%  
Depreciation Rs m058 0.2%   
Interest Rs m014 0.0%   
Profit before tax Rs m1596 15.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m327 9.3%   
Profit after tax Rs m1369 18.3%  
Gross profit margin %5.613.6 41.4%  
Effective tax rate %16.728.3 59.0%   
Net profit margin %5.95.8 102.2%  
BALANCE SHEET DATA
Current assets Rs m268733 36.5%   
Current liabilities Rs m72560 12.8%   
Net working cap to sales %92.114.6 630.2%  
Current ratio x3.71.3 285.6%  
Inventory Days Days14814 1,032.5%  
Debtors Days Days128,898,635108,776 118,498.7%  
Net fixed assets Rs m10336 3.1%   
Share capital Rs m27796 289.9%   
"Free" reserves Rs m-70290 -24.3%   
Net worth Rs m207385 53.7%   
Long term debt Rs m092 0.0%   
Total assets Rs m2781,069 26.0%  
Interest coverage xNM8.0-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.81.1 69.0%   
Return on assets %4.57.7 58.9%  
Return on equity %6.117.8 34.2%  
Return on capital %7.322.9 31.9%  
Exports to sales %00.8 0.0%   
Imports to sales %00.1 0.0%   
Exports (fob) Rs mNA10 0.0%   
Imports (cif) Rs mNA1 0.0%   
Fx inflow Rs m010 0.0%   
Fx outflow Rs m01 0.0%   
Net fx Rs m09 0.0%   
CASH FLOW
From Operations Rs m-21-21 103.0%  
From Investments Rs m-14-16 90.6%  
From Financial Activity Rs m4544 103.0%  
Net Cashflow Rs m107 128.9%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 60.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 36.3 110.4%  
Shareholders   17,121 6,110 280.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENERIC PHARMASEC With:   JD ORGOCHEM  HINDPRAKASH INDUSTRIES  BAGADIA COLOURCHEM  ORGANIC COAT  DYNEMIC PRODUCTS  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Pidilite Results Review: Net Profit Spikes as Sales Rise 121% (Views On News)

Aug 12, 2021

Pidilite posts strong sales growth and a multi-fold jump in bottomline.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GENERIC PHARMASEC SHARE PRICE


Dec 3, 2021 (Close)

TRACK GENERIC PHARMASEC

  • Track your investment in GENERIC PHARMASEC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GENERIC PHARMASEC

GENERIC PHARMASEC - ASAHI SONGWON COMPARISON

COMPARE GENERIC PHARMASEC WITH

MARKET STATS